Automated chest compression devices are medical equipment
used to perform automated external chest compression during cardiac arrest
events and resuscitation. These devices provide consistent, high-quality chest
compressions to patients in cardiac arrest, allowing emergency medical service
personnel to focus on other life-saving interventions such as airway management
and drug administration. Automated chest compression devices ensure that chest
compressions are performed continuously at the correct depth and rate,
minimizing interruptions. The global Automated CPR Devices Market is estimated
to be valued at US$ 127.06 Mn in 2023 and is expected to exhibit a CAGR of 10%
over the forecast period 2023 to 2030, as highlighted in a new report published
by Coherent Market Insights.
Market key trends:
The rising incidence of sudden cardiac arrests across the world is a key factor
driving the growth of the automated CPR devices market. According to the
American Heart Association, over 350,000 out-of-hospital cardiac arrests occur
annually in the United States. Early and high-quality CPR provided by
bystanders or emergency medical service personnel increases the chances of
survival after cardiac arrest. Automated chest compression devices help in
providing consistent, effective CPR to cardiac arrest patients on the scene and
during transportation to hospitals. This improves clinical outcomes and boosts
the survival rates of patients suffering cardiac arrests. The growing adoption
of these devices by emergency medical services and hospitals is expected to
propel the automated CPR devices market during the forecast period.
Segment
Analysis
The global
automated CPR devices market is segmented into piston driven devices and load
distributing devices. The piston-driven devices segment is dominating the
market owing to increasing adoption of automated chest compression systems for
cardiac arrest emergencies in hospitals. Piston-driven devices use a simple
mechanism to provide chest compressions through a piston that pushes against
the chest automatically at regular intervals to circulate blood and oxygen in
the body during cardiac arrest.
Key Takeaways
Regional analysis: North America
region is dominating the automated CPR devices market owing to growing
incidences of cardiac arrest cases, developed healthcare infrastructure and availability
of advanced life-saving devices. The United States accounts for the largest
share in the North America automated CPR devices market due to increasing
adoption of automated CPR devices for emergency cardiac care in hospitals.
Key players operating in the automated CPR devices market are AbD Serotec (a
Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman
Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic
Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc.,
Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva
Pharmaceutical Industries Ltd. Companies operating in the market are focusing
on new product launches and geographical expansion strategies to strengthen
their market position.
Get
more insights on this topic: https://www.newswirestats.com/automated-cpr-devices-market-industry-insights-trends-automated-cpr-devices-market/
Comments
Post a Comment